Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Potential Trump pick for FDA chief lacks medical experience, prompting concerns

December 9, 2016 By Sarah Faulkner

[Image courtesy of Jon Tyson on Unsplash]

President-elect Donald Trump is reportedly considering Jim O’Neill, a libertarian and Silicon Valley investor with no medical experience, as head of the FDA and that has some healthcare experts concerned.

O’Neill has made controversial statements about the federal safety watchdog, including in 2014 when he said that the agency should no longer evaluate whether medical devices or drugs are effective when considering them for approval.

“We should reform FDA so that it’s approving drugs after their sponsors have demonstrated safety and let people start using them at their own risk, but not much risk of safety,” O’Neill said, according to The Hill. “But let’s prove efficacy after they’ve been legalized.”

The comment was viewed harshly by experts, with some saying that it demonstrates how O’Neill’s lack of medical experience could be a problem. A medical background is usually considered a prerequisite for the position as FDA chair.

Peter Pitts, a former FDA associate commissioner under President George W. Bush, pointed out that it’s nearly impossible to separate safety and efficacy when considering pharmaceuticals.

“People need to understand that safety doesn’t exist without the balance of risk,” Pitts told the website, explaining that “every drug has risks” with the example of side effects that might be acceptable for a lung cancer drug but not aspirin.

It is still unclear whom Trump will nominate; anyone he selects will have to be confirmed by the Senate. Former FDA official Dr. Scott Gottlieb is also reportedly under consideration.

Experts have also expressed alarm over O’Neill’s interest in anti-aging products and his claim that immortality could be a possibility within the next 40 years.

“You can tell a lot about an era by listening to what people whine about,” O’Neill has said. “If we invest wisely in life extension technologies, in 40 years, we’ll all be able to annoy our friends with complaints like ‘immortality almost never works.'”

O’Neill has served as principal associate deputy secretary of the Health & Human Services Dept. under the 2nd President Bush.

“He is stunningly unqualified in terms of his understanding of medicine,” director of Public Citizen’s health research group Dr. Michael Carome said, noting that he was “just stunned” when he heard that Trump was mulling O’Neill as FDA chief.

O’Neill has also made suggestions that people should be allowed to be paid to donate their organs, an idea that is largely rejected by healthcare experts.

“There are plenty of healthy spare kidneys walking around, unused,” he once said, according to Stat News. 

Diana Zuckerman, president of the National Center for Health Research, said that O’Neill’s proposals, particularly about excluding efficacy when considering a drug for approval, could cause chaos between insurance companies and the drugs they decide to cover.

“It would throw the entire U.S. healthcare system into turmoil,” she said.  

Related Articles Read More >

Big 100: Steris logo - Largest Medical Device Companies
Steris discloses pay for top executives and its median employee
An illustration of the Endogenex ReCET system inside a patient.
This minimally invasive diabetes device delivers pulsed field energy in the gut
A photo of Steri-Tek CEO Larry Nichols and IBA Deputy CEO Henri de Romrée
Steri-Tek plans sterilization capacity expansion with IBA X-ray irradiation
An image of an infusion pump.
Cybersecurity report flags device vulnerabilities and user needs
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe